These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24024759)

  • 1. Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit.
    Jiang SP; Zhu ZY; Ma KF; Zheng X; Lu XY
    Scand J Infect Dis; 2013 Dec; 45(12):891-9. PubMed ID: 24024759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment.
    Jiang SP; Xu YY; Ping-Yang ; Wu WF; Zhang XG; Lu XY; Xiao YH; Liang WF; Chen J
    Eur J Intern Med; 2014 Dec; 25(10):930-5. PubMed ID: 25153537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of pharmaceutical care in an intensive care unit from China. A pre- and post-intervention study.
    Jiang SP; Zheng X; Li X; Lu XY
    Saudi Med J; 2012 Jul; 33(7):756-62. PubMed ID: 22821310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of pharmacist dosing adjustment for critically ill patients receiving continuous renal replacement therapy: a comparative study.
    Jiang SP; Zhu ZY; Wu XL; Lu XY; Zhang XG; Wu BH
    Ther Clin Risk Manag; 2014; 10():405-12. PubMed ID: 24940066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent hemodialysis versus continuous renal replacement therapy for acute renal failure in the intensive care unit: an observational outcomes analysis.
    Rauf AA; Long KH; Gajic O; Anderson SS; Swaminathan L; Albright RC
    J Intensive Care Med; 2008; 23(3):195-203. PubMed ID: 18474503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
    Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
    Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
    Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
    Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units.
    Kucukarslan SN; Peters M; Mlynarek M; Nafziger DA
    Arch Intern Med; 2003 Sep; 163(17):2014-8. PubMed ID: 14504113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical considerations for the dosing and adjustment of continuous renal replacement therapy in the intensive care unit.
    Galvagno SM; Hong CM; Lissauer ME; Baker AK; Murthi SB; Herr DL; Stein DM
    J Crit Care; 2013 Dec; 28(6):1019-26. PubMed ID: 23890937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new approach on assessing clinical pharmacists' impact on prescribing errors in a surgical intensive care unit.
    Kessemeier N; Meyn D; Hoeckel M; Reitze J; Culmsee C; Tryba M
    Int J Clin Pharm; 2019 Oct; 41(5):1184-1192. PubMed ID: 31332648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.
    Heintz BH; Matzke GR; Dager WE
    Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
    Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
    JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial.
    Lins RL; Elseviers MM; Van der Niepen P; Hoste E; Malbrain ML; Damas P; Devriendt J;
    Nephrol Dial Transplant; 2009 Feb; 24(2):512-8. PubMed ID: 18854418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and antimicrobial dosing adjustment in critically ill patients during continuous renal replacement therapy.
    Kuang D; Verbine A; Ronco C
    Clin Nephrol; 2007 May; 67(5):267-84. PubMed ID: 17542336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication errors recovered by emergency department pharmacists.
    Rothschild JM; Churchill W; Erickson A; Munz K; Schuur JD; Salzberg CA; Lewinski D; Shane R; Aazami R; Patka J; Jaggers R; Steffenhagen A; Rough S; Bates DW
    Ann Emerg Med; 2010 Jun; 55(6):513-21. PubMed ID: 20005011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the impact of a tele-ICU pharmacist on the management of sedation in critically ill mechanically ventilated patients.
    Forni A; Skehan N; Hartman CA; Yogaratnam D; Njoroge M; Schifferdecker C; Lilly CM
    Ann Pharmacother; 2010 Mar; 44(3):432-8. PubMed ID: 20164471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early initiation of continuous renal replacement therapy improves patient survival in severe progressive septic acute kidney injury.
    Oh HJ; Shin DH; Lee MJ; Koo HM; Doh FM; Kim HR; Han JH; Park JT; Han SH; Yoo TH; Choi KH; Kang SW
    J Crit Care; 2012 Dec; 27(6):743.e9-18. PubMed ID: 23084133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of an electronic antimicrobial alert system in intensive care in dosing errors and pharmacist workload.
    Claus BO; Colpaert K; Steurbaut K; De Turck F; Vogelaers DP; Robays H; Decruyenaere J
    Int J Clin Pharm; 2015 Apr; 37(2):387-94. PubMed ID: 25666942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay.
    Marshall J; Finn CA; Theodore AC
    Crit Care Med; 2008 Feb; 36(2):427-33. PubMed ID: 18091554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.